H&R GmbH & Co. KGaA (FRA:2HRA)

Market Cap	186.11M
Revenue (ttm)	1.36B
Net Income (ttm)	11.05M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	16.85
Forward PE	n/a
Dividend	0.10 (2.00%)
Ex-Dividend Date	May 28, 2025

Volume	30,970
Average Volume	37,380
Open	5.02
Previous Close	5.00
Day's Range	5.00 - 5.02
52-Week Range	3.23 - 5.04
Beta	n/a
RSI	64.86
Earnings Date	Aug 15, 2025

About Chimerix

H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts in Europe, Africa, Asia, and internationally. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes...

• Industry: Chemicals and Allied Products
• Founded: 2016
• Employees: 1,705
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2HRA

Financial Performance

In 2024, H&R GmbH & Co. KGaA's revenue was 1.35 billion, a decrease of -1.06% compared to the previous year's 1.36 billion. Earnings were 10.62 million, an increase of 0.63%.